Online citations, reference lists, and bibliographies.
← Back to Search

Correlation Of Dosimetric Factors And Radiation Pneumonitis For Non-small-cell Lung Cancer Patients In A Recently Completed Dose Escalation Study.

E. Yorke, A. Jackson, K. Rosenzweig, L. Braban, S. Leibel, C. Ling
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE To determine dosimetric factors for lung, lung subregions, and heart that correlate with radiation pneumonitis (Radiation Therapy Oncology Group Grade 3 or more) in the 78 evaluable patients from a Phase I dose escalation study (1991-2003) of three-dimensional conformal radiation therapy (3D-CRT) of non-small-cell lung cancer. METHODS AND MATERIALS There were 10 > or = Grade 3 pneumonitis cases within 6 months after treatment. Dose-volume factors analyzed for univariate correlation with > or = Grade 3 pneumonitis were mean dose (MD), effective uniform dose (d(eff)), normal tissue complication probability (NTCP), parallel model f(dam) and V(D) for 5 < or = D < or = 60 Gy for whole, ipsilateral, contralateral, upper and lower halves of the lungs and heart D05, and mean and maximum doses. RESULTS The most significant variables (0.005 < p < 0.006) were ipsilateral lung V(D) for D < 20 Gy. Also significant (p < 0.05) for ipsilateral lung were V(D) for D < 50 Gy, MD, f(dam) and d(eff); for total lung V(D) (D < 50 Gy), MD, f(dam), d(eff) and NTCP; for lower lung V(D) (D < 60 Gy), MD, f(dam) and d(eff). All variables for upper and contralateral lung were insignificant, as were heart variables. CONCLUSIONS Previously reported correlations between severe pneumonitis and whole lung V13 and with other dose-volume factors of total lung and lower lung are confirmed. The most significant correlations were for (V05-V13) in ipsilateral lung.
This paper references
10.1016/S0360-3016(02)02928-0
Dosimetric predictors of radiation-induced lung injury.
L. Marks (2002)
10.1053/SRAO.2001.23482
Partial irradiation of the lung.
Y. Seppenwoolde (2001)
10.1016/S0360-3016(00)00546-0
Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer.
J. Theuws (2000)
10.1016/S0360-3016(02)02929-2
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
E. Yorke (2002)
10.1016/0360-3016(94)90181-3
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
M. Martel (1994)
10.1016/S0360-3016(03)01352-X
Risk of radiation pneumonitis classified via dosimetric parameters
J. Deasy (2003)
10.1016/S0360-3016(98)00196-5
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
10.1016/S0360-3016(00)00583-6
The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer.
K. Rosenzweig (2000)
10.1016/0167-8140(96)01764-1
Underprediction of human skin erythema at low doses per fraction by the linear quadratic model.
C. Hamilton (1996)
10.1016/S0360-3016(99)00183-2
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
M. Graham (1999)
10.1016/J.IJROBP.2004.04.037
Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
Y. Seppenwoolde (2004)
10.1016/S0167-8140(98)00020-6
Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.
S. L. Kwa (1998)
10.1016/S0360-3016(97)00736-0
Partial volume rat lung irradiation: an evaluation of early DNA damage.
M. A. Khan (1998)
10.1200/JCO.2001.19.1.127
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
J. Hayman (2001)
10.1016/0360-3016(95)00009-N
Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
D. Oetzel (1995)
10.1016/J.IJROBP.2004.06.150
Radiation pneumonitis/fibrosis risk based on dosimetric, clinical, and location-related factors
A. Hope (2004)
10.1016/0167-8140(96)01765-3
Clinical evidence of hypersensitivity to low doses in radiotherapy.
I. Turesson (1996)
10.2307/3583506
Complication probability as assessed from dose-volume histograms.
J. Lyman (1985)
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
K. Rosenzweig (2000)
10.1016/S0360-3016(98)90033-5
A comprehensive three-dimensional radiation treatment planning system.
R. Mohan (1988)
10.1016/0360-3016(94)00477-3
Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury.
G. Morgan (1995)
10.1667/RR3130
Low-Dose Hyper-radiosensitivity: A Consequence of Ineffective Cell Cycle Arrest of Radiation-Damaged G2-Phase Cells
B. Marples (2004)
10.1016/S0167-8140(03)00119-1
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
T. Rancati (2003)
10.1016/0360-3016(91)90172-Z
Fitting of normal tissue tolerance data to an analytic function.
C. Burman (1991)
10.1016/0360-3016(88)90098-3
Treatment volume and tissue tolerance.
H. Withers (1988)
10.1016/S0360-3016(02)03986-X
Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis
Y. Seppenwoolde (2003)
10.1016/J.RADONC.2004.02.015
Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
G. Rodrigues (2004)
10.1016/0360-3016(89)90972-3
Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.
G. Kutcher (1989)
10.1016/S0167-8140(02)00325-0
Partial volume rat lung irradiation; assessment of early DNA damage in different lung regions and effect of radical scavengers.
Mohammed A Khan (2003)
10.1016/S0360-3016(02)03986-X
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
Y. Seppenwoolde (2003)
10.1016/S0360-3016(97)00131-4
Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung.
S. Tucker (1997)
10.1016/S0959-8049(01)80993-X
Low dose hyper-radiosensitivity
M. Joiner (2001)
10.1016/S0360-3016(03)01361-0
Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer
K. Rosenzweig (2003)
10.1016/S0167-8140(03)00132-4
Loco-regional differences in pulmonary function and density after partial rat lung irradiation.
E. M. Wiegman (2003)
10.1016/0360-3016(91)90171-Y
Tolerance of normal tissue to therapeutic irradiation.
B. Emami (1991)
10.1016/S0360-3016(97)00130-2
Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung.
E. Travis (1997)
10.1109/IEMBS.2000.900841
The Lyman and a current parallel model: are they equivalent in predicting radiation induced lung toxicity
E. Yorke (2000)
10.1016/S0360-3016(03)00529-7
Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions.
Hendrik P. Bijl (2003)
10.1016/S0167-8140(97)01907-5
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.
J. Armstrong (1997)
10.1016/J.RADONC.2004.02.005
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
L. Claude (2004)
10.1016/S0360-3016(02)03807-5
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.
K. Tsujino (2003)
10.1016/0167-8140(94)90019-1
Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma.
L. Boersma (1994)
10.1016/S0360-3016(01)01685-6
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
M. L. Hernando (2001)
10.1118/1.597056
Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation.
A. Jackson (1993)
10.1016/S0360-3016(00)01471-1
Low-dose hypersensitivity: current status and possible mechanisms.
M. Joiner (2001)



This paper is referenced by
10.1016/J.IJROBP.2006.03.012
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
10.1120/jacmp.v17i1.5737
Optimal unified combination rule in application of Dempster-Shafer theory to lung cancer radiotherapy dose response outcome analysis.
Y. He (2016)
10.1016/j.ijrobp.2009.06.091
Radiation dose-volume effects in the lung.
L. Marks (2010)
10.2217/fon.13.172
Sparing functional anatomical structures during intensity-modulated radiotherapy: an old problem, a new solution.
Wenyong Tan (2014)
10.1097/JTO.0b013e318272601f
Tomotherapy after Pleurectomy/Decortication or Biopsy for Malignant Pleural Mesothelioma Allows the Delivery of High Dose of Radiation in Patients with Intact Lung
E. Minatel (2012)
10.1093/jrr/rrt047
Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields
S. Tanabe (2013)
10.3892/ol.2012.1053
Fatal pneumonitis associated with postoperative intensity-modulated radiotherapy in lung cancer: Case report and review
Y. Hu (2013)
Radiation DoseVolume Effects in the Lung
L. Marks (2010)
10.1007/978-0-387-36744-6_11
Image-based modeling of normal tissue complication probability for radiation therapy.
J. Deasy (2008)
10.1016/J.SEMRADONC.2006.04.009
The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols.
A. Jackson (2006)
10.1007/S10330-011-0896-2
Study of the impact of CT/CT image fusion radiotherapy on V20 and radiation pneumonitis of non-small cell lung cancer
L. Liu (2012)
10.3109/0284186X.2011.582519
Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer
I. Vogelius (2011)
10.3109/0284186X.2010.521192
Heart irradiation as a risk factor for radiation pneumonitis
E. Huang (2011)
10.1016/j.ijrobp.2009.08.068
Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.
C. H. Song (2010)
10.3389/fonc.2020.584756
Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
Y. Meng (2020)
10.1016/j.ijrobp.2009.02.079
Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers.
J. Jin (2010)
10.1118/1.4813916
Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
Yevegeniy Vinogradskiy (2013)
10.1088/0031-9155/57/17/5575
Application of Dempster-Shafer theory in dose response outcome analysis.
Wenzhou Chen (2012)
10.1016/J.IJROBP.2006.03.063
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Eng-Siew Koh (2006)
10.7150/jca.21158
New Clinical Features and Dosimetric Predictor Identification for Symptomatic Radiation Pneumonitis after Tangential Irradiation in Breast Cancer Patients
Ge Wen (2017)
10.1002/cam4.3446
Simultaneous integrated boost of intensity‐modulated radiation therapy to Stage II‐III non‐small cell lung cancer with metastatic lymph nodes
Q. Li (2020)
Apport de l'imagerie fonctionelle par Tomographie par émissions de positons (TEP) en radiothérapie pulmonaire
S. Thureau (2018)
10.1634/THEONCOLOGIST.11-7-809
Combined modality therapy for stage III non-small cell lung cancer.
T. Stinchcombe (2006)
10.1007/978-2-8178-0021-9_15
Cancer bronchique non à petites cellules
O. N. Pagès (2011)
10.1016/j.ctro.2020.02.004
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
K. A. Al Feghali (2020)
Stereotactic Body Radiotherapy in Non-Small Cell Lung Cancer
P. Baumann (2009)
10.1007/S12094-007-0094-4
Toxicity associated to radiotherapy treatment in lung cancer patients.
M. L. Rodríguez (2007)
10.1109/ICMLA.2008.122
Decision Fusion of Machine Learning Models to Predict Radiotherapy-Induced Lung Pneumonitis
Shiva K. Das (2008)
10.1016/j.ijrobp.2010.01.041
Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years' experience in a single institute: in regard to Karakoyun-Celik et Al. (Int J Radiat Oncol Biol Phys 2010;76:433-439).
Zafer Koçak (2010)
10.1097/CCO.0b013e328341eed6
Chemoradiation therapy in nonsmall cell lung cancer
P. Baas (2011)
10.1016/j.ijrobp.2010.12.073
Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
I. S. Vogelius (2011)
Feasibility study of recalculation of the dose for lung cancer radiotherapy using cone beam computed tomography images from a linear accelerator: a heterogeneous phantom study
Zhipeng Zhao (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar